Full text is available at the source.
Abstract
Recent advances in diabetic kidney disease (DKD) research highlight novel biomarkers associated with mitochondrial dysfunction and oxidative stress.
- Single-cell RNA sequencing and spatial transcriptomics reveal significant cellular diversity and identify maladaptive tubular cell states linked to disease progression.
- Immune dysregulation is recognized as a central factor in the progression of DKD.
- Metabolomics has uncovered early metabolic disturbances that could serve as biomarkers for the disease.
- Artificial intelligence models, such as DeepDKD, show high accuracy in non-invasive screening using retinal images.
- Novel therapeutic agents are being developed to target inflammation, fibrosis, and metabolic pathways beyond traditional treatments.
Simplified